1 completed, 1 recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Malignancies Multiple: new trials by email Literature Review of Malignancies Multiple trials Research Report on Malignancies Multiple
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Effect of 2 Drugs on the Pharmacokinetics of BMS-986205 in Healthy Subjects BMS-986205, Itraconazole, Rifampin - Malignancies Multiple | Phase 1 | Completed | Bristol-Myers Squibb | 53 | 2017-11-22 | 2018-02-28 |
| Anti-PD-1 Antibody Alone or in Combination With Decitabine/Chemotherapy in Relapsed or Refractory Malignancies Anti-PD-1 antibody, Decitabine, Chemotherapy - Malignancies Multiple | Phase 1 / Phase 2 | Recruiting | Han weidong | 250 | 2016-05-01 | 2026-01-22 |
Neoplasms (1) · Recurrence (1)
Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Decitabine (1) · Drug Therapy (1) · Itraconazole (1) · Rifampin (1) · linrodostat (1) · spartalizumab (1)
Bristol-Myers Squibb (1) · Han weidong (1)
China (1) · United States (1)
Chunmeng Wang, Master (1) · Hejin Jia, Doctor (1) · Jing Nie, Doctor (1) · Jingdan Qiu, Doctor (1) · Kaichao Feng, Doctor (1) · Liang Dong, Master (1) · Lu Shi, Master (1) · Meixia Chen, Doctor (1) · Qian Mei, Doctor (1) · Wenying Zhang, Master (1) · Xiang Li, Master (1) · Yan Zhang, Doctor (1) · Yang Liu, Doctor (1)
PMID 25895027, PMID 27191266, PMID 31039052, PMID 33674274, PMID 33820822